Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
LISATA THERAPEUTICS, INC.
| Metric | LISATA THERAPEUTICS, INC. LSTAHealthcare |
|---|---|
| Quality Score | 35 / 100 |
| Revenue (latest) | $170,000 |
| Net income (latest) | −$17M |
| Operating margin | −10711.2% |
| Net margin | −9756.5% |
| Return on equity | −111.7% |
| Return on assets | −93.5% |
| Return on capital (ROCE) | −124.1% |
| Debt / equity | 0.21× |
| Revenue growth (YoY) | −83.0% |
| Altman Z″ (distress) | -100.26 |
| Accruals / assets | −3.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.